Balm Innovations, LLC: A provider of innovative, effective natural healthcare products.

(MENAFNEditorial) BI is a provider of innovative, effective natural healthcare products. The company's initial brand is Omnibalm®, a line of a highly effective, versatile topical creams based on a proprietary formulation licensed from UAMS. Omnibalm's key ingredient is tea tree oil with antiseptic, antifungal, and anti-inflammatory properties. BI is a UAMS BioVentures incubator company formed around the transfer of technology developed in a UAMS pharmaceutical research laboratory. UAMS BioVentures' mission is to translate UAMS' publicly funded research into products that benefit human healthcare and to convert Arkansas' medical and biotechnology research into new companies and high wage jobs for Arkansans. UAMS BioVentures recognizes Balm Innovations as a successful client company supporting this mission.

Products / Services Omnibalm Daily Foot Therapy

Omnibalm Daily Foot Therapy is a non-greasy cream for general and diabetic foot care that softens and helps repair dry, cracked skin and keeps feet healthy and fresh. The proprietary formula combines moisturizers with 13% of the highest quality tea tree oil, a naturally powerful essential oil with antiseptic and antifungal properties, which helps keep feet healthy and fresh. Tea tree oil from Australia has been used for centuries for its remarkable healing properties and is now recognized as a safe, effective natural skin care ingredient.

Omnibalm is a multipurpose, non-greasy cream that provides soothing, moisturizing therapy for dry skin, cracking, itching, daily foot care, sun damaged skin, chafing, roughness, and other skin irritations. The proprietary formula combines moisturizers with 13% of the highest quality tea tree oil, a naturally powerful essential oil with antiseptic and anti-inflammatory properties. Tea tree oil from Australia has been used for centuries for its remarkable healing properties and is now recognized as a safe, effective natural skin care ingredient.

Omnibalm Cucumber Melon is a multipurpose, non-greasy cream with a clean, refreshing scent that provides soothing, moisturizing therapy for dry skin, cracking, itching, daily foot care, sun damaged skin, chafing, roughness, and other skin irritations. The proprietary formula combines moisturizers a high concentration of high quality tea tree oil, a naturally powerful essential oil with antiseptic and anti-inflammatory properties. Tea tree oil from Australia has been used for centuries for its remarkable healing properties. This product is being discontinued as Daily Foot Therapy is introduced.

BI plans to launch Omnibalm Skin Repair Cream, an O-T-C drug skin protectant, later this year. It is a multipurpose, non-greasy cream that provides healing therapy for dry/cracked skin, itching, minor burns/sunburn, minor cuts/scrapes, and similar skin irritations. Its proprietary formula combines moisturizers with 13% of the highest quality tea tree oil, a naturally powerful essential oil with antiseptic and anti-inflammatory properties. Tea tree oil from Australia has been used for centuries for its remarkable healing properties and is a safe, effective natural skin care ingredient.

Founded BI - Obtained UAMS license for exclusive technology rights. Led successful launch of 3 products. ASTA VP Industry and AR Mfg. Solutions Director 2/01-8/07 - AMS consistently recognized as a top performing MEP center in U.S. AMS Field Engineer 4 yrs Consulted with AR manufacturers. Engineering roles at Lexmark International and Ford Motor Co. Vanderbilt BE, Mech. Engineering, cum laude. UALR MBA - Outstanding Executive MBA Student. Planet Eureka! Natl. Innovation Marketplace Advisory Board. U.S. DoC appointments: AR District Export Council, MEP Natl. Advisory Board. ASME Strategic Initiatives & Innovation Committee. AR Small Business Council, Chair. National Assn. of Women Business Owners Central AR Chap. Board - Rising Star Award. Leadership AR Class I. AR Business 40 under 40.

Developer of Omnibalm.
UAMS Clinical Pharmacokinetics Research Laboratory Director.
Professor of Pharmaceutical Sciences, UAMS College of Pharmacy.
Investigator for numerous research grants.
More than 100 peer-reviewed publications re: pharmacokinetics, analytical method development, therapeutic drug monitoring, herbal dietary supplements, and herb-drug interactions.
Studies involving safety of ephedra dietary supplements and herb-drug interactions cited in NY Times, LA Times, Washington Post, Chicago Tribune, The Wall Street Journal, Newsweek, Reader's Digest, U.S. News & World Report, Consumer Reports.
Appearances: Dateline NBC, MSNBC, CNN, Fox News, ESPN, Good Morning America.
BS in Chemistry and Pharmacy.
Ph.D. in Pharmaceutics.
Reviewer for 18 scientific journals.

Mark Saviers is Fund for Arkansas' Futures' BI Board of Managers representative and is on the Advisory Board that meets bimonthly. Mr. Saviers' received a warrant with rights to purchase BI equity as compensation for being a Manager. His experience in marketing and sales and as an entrepreneur is invaluable to BI. Currently, Mr. Saviers is a Partner with Sage Partners, a commercial real estate firm, and is the Managing Partner of a development partnership in Houston. Mr. Saviers has over 23 years of experience developing over $300 million in business parks, corporate headquarters, etc. He is a member of the Accelerate Arkansas Executive Committee and is a Board member of Arkansas Children's Hospital, Arkansas Children's Hospital Research Institute, and the Arkansas Biosciences Institute.

MENAFN2805201700703403ID1095520633

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.